Nature Communications (Nov 2020)

Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease

  • Kate L. Bowerman,
  • Saima Firdous Rehman,
  • Annalicia Vaughan,
  • Nancy Lachner,
  • Kurtis F. Budden,
  • Richard Y. Kim,
  • David L. A. Wood,
  • Shaan L. Gellatly,
  • Shakti D. Shukla,
  • Lisa G. Wood,
  • Ian A. Yang,
  • Peter A. Wark,
  • Philip Hugenholtz,
  • Philip M. Hansbro

DOI
https://doi.org/10.1038/s41467-020-19701-0
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 15

Abstract

Read online

Chronic obstructive pulmonary disease (COPD) is a progressing disease, with lung but not gut microbiota implicated in its etiology. Here the authors compare the stool from patients with COPD and healthy controls to find specific gut bacteria and metabolites associated with active disease, thereby hinting at a potential role for the gut microbiome in COPD.